TickerHumNYSE · Healthcare · Medical Instruments & Supplies
Becton, Dickinson and Company (BDX)
As of Nov 11, 1:50 PM ET, Becton, Dickinson and (BDX) last traded at $212.48, down 0.06% on the day. Its TickerHum research score is 52/100 (average). It reported revenue of $22.48B for the twelve months ending 2026-06-30, up 18.5% year over year, with a 10.7% operating margin.
Ratings
- Valuation: 46/100 — Strongest input: price / sales (ttm) 2.6x. Weakest: price / earnings (ttm) 64.2x.
- Growth: 36/100 — Strongest input: revenue growth (ttm, yoy) +18.5 %. Weakest: diluted eps growth (ttm, yoy) -39.5 %.
- Profitability: 35/100 — Strongest input: operating margin 10.7 %. Weakest: return on equity 3.9 %.
- Financial health: 29/100 — Strongest input: long-term debt / equity 0.55. Weakest: cash / long-term debt 0.05.
- Momentum: 91/100 — Strongest input: 6-month return +47.4 %. Weakest: 1-year return +40.7 %.
- Attention: 40/100 — Strongest input: headlines in the last 7 days 12. Weakest: volume vs 3-month average 0.3x.
- Risk resilience: 74/100 — Strongest input: annualised volatility (1y) 26.2 %. Weakest: max drawdown (1y) -24.1 %.
- Data confidence: 95/100 — Strongest input: quote age (hours) 0 h. Weakest: inputs available 90 %.
Reported fundamentals
| Metric | Value | Period |
|---|---|---|
| Revenue | $22.48B | TTM ending 2026-06-30 · 10-Q |
| Revenue growth | 18.5% | TTM ending 2026-06-30 · 10-Q |
| Net income | $942M | TTM ending 2026-06-30 · 10-Q |
| Diluted EPS | $3.31 | TTM ending 2026-06-30 · 10-Q |
| Operating margin | 10.7% | TTM ending 2026-06-30 · 10-Q |
| Net margin | 4.2% | TTM ending 2026-06-30 · 10-Q |
| Cash | $708M | as of 2026-06-30 · 10-Q |
| Long-term debt | $13.51B | as of 2026-06-30 · 10-Q |
| Debt / equity | 0.55 | as of 2026-06-30 · 10-Q |
Source: SEC EDGAR XBRL company facts (CIK 0000010795).
Comparable companies for Becton, Dickinson and
Selected by industry, business overlap and scale; these are not necessarily direct competitors.
- Becton, Dickinson and vs Intuitive Surgical (BDX vs ISRG) — Same industry (Medical Instruments & Supplies); market cap 2.7x
- Becton, Dickinson and vs Abbott Laboratories (BDX vs ABT) — Same sector (Healthcare), different industry; market cap 3.3x; shares: diagnostics
- Becton, Dickinson and vs Boston Scientific (BDX vs BSX) — Same sector (Healthcare), different industry; market cap 1.1x
- Becton, Dickinson and vs The Cigna Group (BDX vs CI) — Same sector (Healthcare), different industry; market cap 1.4x
- Becton, Dickinson and vs Biogen (BDX vs BIIB) — Same sector (Healthcare), different industry; market cap 0.64x
Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.